全文获取类型
收费全文 | 36185篇 |
免费 | 2229篇 |
国内免费 | 97篇 |
专业分类
耳鼻咽喉 | 368篇 |
儿科学 | 880篇 |
妇产科学 | 752篇 |
基础医学 | 4772篇 |
口腔科学 | 781篇 |
临床医学 | 3346篇 |
内科学 | 7516篇 |
皮肤病学 | 553篇 |
神经病学 | 3891篇 |
特种医学 | 1447篇 |
外国民族医学 | 55篇 |
外科学 | 4764篇 |
综合类 | 451篇 |
一般理论 | 16篇 |
预防医学 | 3152篇 |
眼科学 | 941篇 |
药学 | 2466篇 |
中国医学 | 34篇 |
肿瘤学 | 2326篇 |
出版年
2023年 | 120篇 |
2022年 | 252篇 |
2021年 | 557篇 |
2020年 | 314篇 |
2019年 | 547篇 |
2018年 | 622篇 |
2017年 | 514篇 |
2016年 | 541篇 |
2015年 | 708篇 |
2014年 | 993篇 |
2013年 | 1454篇 |
2012年 | 2199篇 |
2011年 | 2310篇 |
2010年 | 1267篇 |
2009年 | 1204篇 |
2008年 | 2105篇 |
2007年 | 2325篇 |
2006年 | 2209篇 |
2005年 | 2204篇 |
2004年 | 2095篇 |
2003年 | 1953篇 |
2002年 | 1857篇 |
2001年 | 490篇 |
2000年 | 402篇 |
1999年 | 430篇 |
1998年 | 412篇 |
1997年 | 376篇 |
1996年 | 316篇 |
1995年 | 312篇 |
1994年 | 257篇 |
1993年 | 256篇 |
1992年 | 266篇 |
1991年 | 229篇 |
1990年 | 217篇 |
1989年 | 252篇 |
1988年 | 224篇 |
1987年 | 214篇 |
1986年 | 191篇 |
1985年 | 191篇 |
1984年 | 251篇 |
1983年 | 210篇 |
1982年 | 251篇 |
1981年 | 227篇 |
1980年 | 207篇 |
1979年 | 173篇 |
1978年 | 166篇 |
1976年 | 151篇 |
1975年 | 132篇 |
1974年 | 157篇 |
1973年 | 118篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
911.
912.
913.
Jon Banks Fiona M Walter Nicola Hall Katie Mills William Hamilton Katrina M Turner 《The British journal of general practice》2014,64(629):e775-e782
Background
The challenge for GPs when assessing whether to refer a patient for cancer investigation is that many cancer symptoms are also caused by benign self-limiting illness. UK National Institute for Health and Care Excellence (NICE) referral guidelines emphasise that the patient should be involved in the decision-making process and be informed of the reasons for referral. Research to date, however, has not examined the extent to which these guidelines are borne out in practice.Aim
To assess the degree to which patients are involved in the decision to be referred for investigation for symptoms associated with cancer and their understanding of the referral.Design and setting
Qualitative interview study of patients referred to secondary care for symptoms suspicious of lung and colorectal cancer. Patients were recruited from two regions of England using maximum variation sampling.Method
Transcribed interviews were analysed thematically.Results
The analysis was based on 34 patient interviews. Patients in both symptom pathways reported little involvement in the decision to be referred for investigation. This tended to be accompanied by a patient expectation for referral, however, to explain ongoing and un-resolving symptoms. It was also found that reasons for referral tended to be couched in non-specific terms rather than cancer investigation, even when the patient was on a cancer-specific pathway.Conclusion
GPs should consider a more overt discussion with patients when referring them for further investigation of symptoms suspicious of cancer. This would align clinical practice with NICE guidelines and encourage more open discussion between GPs and primary care patients around cancer. 相似文献914.
Lalini Raghoebir Katharina Biermann Marjon Buscop-van Kempen Hendrikus J. Dubbink Winand N. M. Dinjens Remko Hersmus Leendert H. J. Looijenga Marco J. Bruno Dick Tibboel Robbert J. Rottier Ron Smits 《Virchows Archiv : an international journal of pathology》2014,465(4):395-400
Colorectal cancer (CRC) can be divided into non-mucinous and mucinous subtypes, of which the latter portends to have a worse clinical prognosis. A previous study suggested a putative link between SOX2 expression observed selectively in mucinous CRC and the induction of the gastric mucin MUC5AC. In this study, we re-evaluated the expression behavior of SOX2, MUC5AC, and CDX2 in both types of CRC. We performed immunohistochemical analysis on 90 cases of non-mucinous CRCs, 57 cases of mucinous CRCs, and 15 case-matched normal intestinal mucosa. In contrast to the previously suggested link between SOX2 and mucinous CRC, we observe aberrant expression of SOX2 at equal levels in both subtypes. Fluorescence in situ hybridization (FISH) analysis shows that expression is not attributed to genomic amplification. While SOX2 and CDX2 are normally expressed in a reciprocal manner, SOX2-positive tumor cells co-express CDX2. Furthermore, we show that MUC5AC is expressed independently of SOX2. In conclusion, we show that aberrant SOX2 expression is specifically linked neither to mucinous CRCs nor to the induction of MUC5AC, in contrast to previous suggestions. 相似文献
915.
Lili Zhang Marianne Gallup Lorna Zlock Yu Ting Feeling Chen Walter E Finkbeiner Nancy A McNamara 《The Journal of pathology》2014,234(1):60-73
Cigarette smoke increases the risk of lung cancer by 20‐fold and accounts for 87% of lung cancer deaths. In the normal airway, heavily O‐glycosylated mucin‐1 (MUC1) and adherens junctions (AJs) establish a structural barrier that protects the airway from infectious, inflammatory and noxious stimuli. Smoke disrupts cell–cell adhesion via its damaging effects on the AJ protein epithelial cadherin (E‐cad). Loss of E‐cad is a major hallmark of epithelial–mesenchymal transition (EMT) and has been reported in lung cancer, where it is associated with invasion, metastasis and poor prognosis. Using organotypic cultures of primary human bronchial epithelial (HBE) cells treated with smoke‐concentrated medium (Smk), we have demonstrated that E‐cad loss is regulated through the aberrant interaction of its AJ binding partner, p120‐catenin (p120ctn), and the C‐terminus of MUC1 (MUC1‐C). Here, we reported that even before MUC1‐C became bound to p120ctn, smoke promoted the generation of a novel 400 kDa glycoform of MUC1's N‐terminus (MUC1‐N) differing from the 230 kDa and 150 kDa glycoforms in untreated control cells. The subsequent smoke‐induced, time‐dependent shedding of glycosylated MUC1‐N exposed MUC1‐C as a putative receptor for interactions with EGFR, Src and p120ctn. Smoke‐induced MUC1‐C glycosylation modulated MUC1‐C tyrosine phosphorylation (TyrP) that was essential for MUC1‐C/p120ctn interaction through dose‐dependent bridging of Src/MUC1‐C/galectin‐3/EGFR signalosomes. Chemical deglycosylation of MUC1 using a mixture of N‐glycosylation inhibitor tunicamycin and O‐glycosylation inhibitor benzyl‐α‐GalNAc disrupted the Src/MUC1‐C/galectin‐3/EGFR complexes and thereby abolished smoke‐induced MUC1‐C‐TyrP and MUC1‐C/p120ctn interaction. Similarly, inhibition of smoke‐induced MUC1‐N glycosylation using adenoviral shRNA directed against N‐acetyl‐galactosaminyl transferase‐6 (GALNT6, an enzyme that controls the initiating step of O‐glycosylation) successfully suppressed MUC1‐C/p120ctn interaction, prevented E‐cad degradation and maintained cellular polarity in response to smoke. Thus, GALNT6 shRNA represents a potential therapeutic modality to prevent the initiation of events associated with EMT in the smoker's airway. Copyright © 2014 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd. 相似文献
916.
917.
918.
We describe the preparation of nanocomposites which exhibit dichroism in the near infrared region (NIR). These materials consist of crosslinked poly(dimethylsiloxane) (PDMS) and gold nanoparticles, coated with 1-dodecanethiol or tert-tetradecanethiol. The alkanethiols improve dispersibility of the gold particles, and accordingly composites were manufactured by diffusion of the particles into swollen self-supporting PDMS elastomer films. After drying, the films were exposed to solvents for one minute, stretched in wet state, dried again and annealed. This procedure led to formation of oriented linear gold particle assemblies within stretched polymer. If the aspect ratio of the particle assemblies is high, the absorption of polarized light in the NIR region is expected to depend on the angle between the polarization plane and the orientation direction of the particle assemblies, and this was observed to be the case. 相似文献
919.